Obesity, reproduction and oxidative stress
https://doi.org/10.14341/omet2017416-22
Abstract
The prevalence of obesity and overweight is one of the most pressing problems nowadays. Obesity as a comorbid condition affects all body systems. Obesity has been reported to be a risk factor not only for cardiovascular diseases and oncopathology, but also for fertility problems, many obstetric and perinatal complications worsening the maternal and infant health. The balance between the oxidative and antioxidant system is one of the indicators of the state of human homeostasis. Today it is proved that obesity is associated with an increase in oxidative stress and a decrease in antioxidant protection. This review reveals a close relationship between obesity, oxidative stress and reproductive problems.
About the Authors
Tamara V. ZhukAltay State Medical University
Russian Federation
Рostgraduate student
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи
Svetlana D. Yavorskaya
Altay State Medical University
Russian Federation
ScD, Associate Professor
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи
Vjacheslav V. Vostrikov
Siberian Institute of a reproduction and genetics of the person
Russian Federation
PhD, Associate Professor
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи
References
1. www.who.int/ru/ [интернет]. Всемирная организация здравоохранения. «Ожирение и избыточный вес» [доступ от: 07.03.2017 г.] Доступ по ссылке: http://www.who.int/mediacentre/factsheets/fs311/ru/ [WHO Fact sheet «Obesity and overweight», 2017. Available from: http://www.who.int/mediacentre/factsheets/fs311/ru/] Ссылка активна на 01.12.2017
2. Wronska A, Kmiec Z. Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiologica. 2012;205(2):194-208. doi: 10.1111/j.1748-1716.2012.02409.x.
3. Караман Ю.К. Механизмы адаптации организма к алиментарной высокожировой нагрузке: Дис. д-ра биол. наук. – Владивосток; 2011. [Karaman YuK. Mekhanizmy adaptatsii organizma k alimentarnoi vysokozhirovoi nagruzke. [dissertation] Vladivostok; 2011. (In Russ).]
4. Меситов М.В., Игнашкова Т.И., Мещерский М.Е., и др. Индукция стресса эндоплазматического ретикулума в условиях окислительно-восстановительного дисбаланса в клетках Т-лимфобластах лейкемии человека. // Патологическая физиология и экспериментальная терапия. – 2012.– №3. – С. 87-93. [Mesitov MV, Ignashkova TI, Meshcherskii ME, et al. Induktsiya stressa endoplazmaticheskogo retikuluma v usloviyakh okislitel'no-vosstanovitel'nogo disbalansa v kletkakh T-limfoblastakh leikemii cheloveka. Patologicheskaya fisiologiya i eksperimental'naya terapiya. 2012;(3):87-93. (In Russ).]
5. Хаитов Р.М., Манько В.М., Ярилин А.А. Внутриклеточные сигнальные пути, активирующие или ингибирующие функции клеток иммунной системы. Внутриклеточные сигнальные пути при апоптозе. // Успехи современной биологии. –2006. –Т. 126.– №1. – С. 3-9. [Khaitov RM, Man'ko VM, Yarilin AA. Intracellular Signal Ways Activating or Inhibiting Functions of Immune System Cells. Intracellular Signal Ways in Apoptosis. Biology Bulletin Reviews. 2006;126(1):3-9. (In Russ).]
6. Kaneko H, Anzai T, Nagai T, et al. Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling. Cardiovasc Res. 2011;91(3):546-555. doi: 10.1093/cvr/cvr088.
7. Poitou C, Coussieu C, Rouault C, et al. Serum Amyloid A: A Marker of Adiposity-induced Low-grade Inflammation but Not of Metabolic Status*. Obesity. 2006;14(2):309-318. doi: 10.1038/oby.2006.40.
8. Кайдашев И.П. Активация ядерного фактора κB как молекулярной основы патогенеза метаболического синдрома // Патологическая физиология и экспериментальная терапия. – 2013. – №3. – С. 65-72. [Kaidashev IP. Conception for permanent activation of nuclear factor kB as molecular basis for metabolic syndrom pathogenesis. Patologicheskaya fisiologiya i eksperimental'naya terapiya. 2013; (3):65-72. (In Russ).]
9. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2007;60(03):329-339. doi: 10.1079/pns200194.
10. Imai A, Komatsu S, Ohara T, et al. Visceral abdominal fat accumulation predicts the progression of noncalcified coronary plaque. Atherosclerosis. 2012;222(2):524-529. doi: 10.1016/j.atherosclerosis.2012.03.018.
11. Unger RH, Scherer PE, Holland WL. Dichotomous roles of leptin and adiponectin as enforcers against lipotoxicity during feast and famine. Mol Biol Cell. 2013;24(19):3011-3015. doi: 10.1091/mbc.E12-10-0774.
12. Majka SM, Miller HL, Helm KM, et al. Analysis and Isolation of Adipocytes by Flow Cytometry. Methods. Enzymol. 2014;537:281-296. doi: 10.1016/b978-0-12-411619-1.00015-x.
13. Osawa K, Miyoshi T, Koyama Y, et al. Differential association of visceral adipose tissue with coronary plaque characteristics in patients with and without diabetes mellitus. Cardiovascular Diabetology. 2014;13(1):61. doi: 10.1186/1475-2840-13-61.
14. Окороков П.Л., Васюкова О.В., Воронцов А.В. Методы оценки количества и распределения жировой ткани в организме и их клиническое значение // Проблемы эндокринологии. – 2014. – Т.60. – №3. – С. 53-58. [Okorokov PL, Vasyukova OV, Vorontsov AV. The methods for the characteristic of adipose tissue in the organism and their clinical significance. Problems of Endocrinology. 2014; 60(3):53-58. (in Russ)] doi: 10.14341/probl201460353-58.
15. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129-139. doi: 10.1016/j.mce.2009.08.018.
16. Norman RJ, Clark AM. Obesity and reproductive disorders: a review. Reprod Fertil Dev. 1998;10(1):55. doi: 10.1071/r98010.
17. Freeman E, Gracia C, Sammel M, et al. Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril. 2007;87(1):101-106. doi: 10.1016/j.fertnstert.2006.05.074.
18. Metwally M, Li TC, Ledger WL. The impact of obesity on female reproductive function. Obes Rev. 2007;8(6):515-523. doi: 10.1111/j.1467-789X.2007.00406.x.
19. Wise LA, Rothman KJ, Mikkelsen EM, et al. An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod. 2009;25(1):253-264. doi: 10.1093/humrep/dep360.
20. Vahratian A, Smith YR. Should access to fertility-related services be conditional on body mass index? Hum Reprod. 2009;24(7):1532-1537. doi: 10.1093/humrep/dep057.
21. Boots C, Stephenson M. Does Obesity Increase the Risk of Miscarriage in Spontaneous Conception: A Systematic Review. Semin Reprod Med. 2011;29(06):507-513. doi: 10.1055/s-0031-1293204.
22. Lutsiv O, Mah J, Beyene J, McDonald SD. The effects of morbid obesity on maternal and neonatal health outcomes: a systematic review and meta-analyses. Obes Rev. 2015;16(7):531-546. doi: 10.1111/obr.12283.
23. Gray G, Nelson-Piercy C. Thromboembolic disorders in obstetrics. Best Practice & Research Clinical Obstetrics & Gynaecology. 2012;26(1):53-64. doi: 10.1016/j.bpobgyn.2011.10.003.
24. Despres JP, Lemieux I, Bergeron J, et al. Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039-1049. doi: 10.1161/atvbaha.107.159228.
25. Romero R, Espinoza J, Kusanovic JP, et al. The preterm parturition syndrome. BJOG: An International Journal of Obstetrics & Gynaecology. 2006;113:17-42. doi: 10.1111/j.1471-0528.2006.01120.x.
26. Kapoor D, Rajendran S. Can we improve care and outcomes of pregnancy in women with morbid obesity? BJOG. 2013;120:30-31.
27. Opray N, Grivell RM, Deussen AR, et al. Directed preconception health programs and interventions for improving pregnancy outcomes for women who are overweight or obese. Cochrane Database of Systematic Reviews 2015, Issue 7. Art. No.: CD010932 doi: 10.1002/14651858.CD010932.pub2.
28. Jungheim ES, Moley KH. Current knowledge of obesity's effects in the pre- and periconceptional periods and avenues for future research. Am J Obstet Gynecol. 2010;203(6):525-530. doi: 10.1016/j.ajog.2010.06.043.
29. Steinkampf MP, Hammond KR, Nichols JE, Slayden SH. Effect of obesity on recombinant follicle-stimulating hormone absorption: subcutaneous versus intramuscular administration. Fertil Steril. 2003;80(1):99-102. doi: 10.1016/s0015-0282(03)00566-1.
30. Shah DK, Missmer SA, Berry KF, et al. Effect of Obesity on Oocyte and Embryo Quality in Women Undergoing In Vitro Fertilization. Obstet Gynecol. 2011;118(1):63-70. doi: 10.1097/AOG.0b013e31821fd360.
31. Zander-Fox DL, Henshaw R, Hamilton H, Lane M. Does obesity really matter? The impact of BMI on embryo quality and pregnancy outcomes after IVF in women aged ≤38 years. Aust N Z J Obstet Gynaecol. 2012;52(3):270-276. doi: 10.1111/j.1479-828X.2012.01453.x.
32. Rittenberg V, Sobaleva S, Ahmad A, et al. Influence of BMI on risk of miscarriage after single blastocyst transfer. Hum Reprod. 2011;26(10):2642-2650. doi: 10.1093/humrep/der254.
33. Robker RL, Akison LK, Bennett BD, et al. Obese Women Exhibit Differences in Ovarian Metabolites, Hormones, and Gene Expression Compared with Moderate-Weight Women. J Clin Endocr Metab. 2009;94(5):1533-1540. doi: 10.1210/jc.2008-2648.
34. Jungheim ES, Schoeller EL, Marquard KL, et al. Diet-Induced Obesity Model: Abnormal Oocytes and Persistent Growth Abnormalities in the Offspring. Endocrinology. 2010;151(8):4039-4046. doi: 10.1210/en.2010-0098.
35. Leary C, Leese HJ, Sturmey RG. Human embryos from overweight and obese women display phenotypic and metabolic abnormalities. Hum Reprod. 2014;30(1):122-132. doi: 10.1093/humrep/deu276.
36. Bellver J, Melo MAB, Bosch E, et al. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril. 2007;88(2):446-451. doi: 10.1016/j.fertnstert.2006.11.162.
37. Bellver J, Pellicer A, García-Velasco JA, et al. Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors. Fertil Steril. 2013;100(4):1050-1058.e1052. doi: 10.1016/j.fertnstert.2013.06.001.
38. Metwally M, Preece R, Thomas J, et al. A proteomic analysis of the endometrium in obese and overweight women with recurrent miscarriage: preliminary evidence for an endometrial defect. Reprod Biol Endocrinol. 2014;12(1):75. doi: 10.1186/1477-7827-12-75.
39. Barboza IC, Depes DdB, Vianna Júnior I, et al. Analysis of endometrial thickness measured by transvaginal ultrasonography in obese patients. Einstein (São Paulo). 2014;12(2):164-167. doi: 10.1590/s1679-45082014ao2838.
40. Sim KA, Partridge SR, Sainsbury A. Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review. Obes Rev. 2014;15(10):839-850. doi: 10.1111/obr.12217.
41. Burton GJ, Jauniaux E. Oxidative stress. Best Practice & Research Clinical Obstetrics & Gynaecology. 2011;25(3):287-299. doi: 10.1016/j.bpobgyn.2010.10.016.
42. Auten RL, Davis JM. Oxygen Toxicity and Reactive Oxygen Species: The Devil Is in the Details. Pediatr Res. 2009;66(2):121-127. doi: 10.1203/PDR.0b013e3181a9eafb.
43. Agarwal A, Aziz N, Rizk B. Studies on Women's Health. HumanaPress, NewYork; 2013; рр 33–60. doi:https://doi.org/10.1007/978-1-62703-041-0.
44. Agarwal A, Aponte-Mellado A, Premkumar BJ, et al. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10(1):49. doi: 10.1186/1477-7827-10-49.
45. Redman CWG, Sargent IL. Pre-eclampsia, the Placenta and the Maternal Systemic Inflammatory Response–A Review. Placenta. 2003;24:S21-S27. doi: 10.1053/plac.2002.0930.
46. Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav. 2008;94(2):206-218. doi: 10.1016/j.physbeh.2007.10.010.
47. Wenceslau CF, McCarthy CG, Szasz T, et al. Mitochondrial damage-associated molecular patterns and vascular function. Eur Heart J. 2014;35(18):1172-1177. doi: 10.1093/eurheartj/ehu047.
48. Khan NI, Naz L, Yasmeen G. Obesity: an independent risk factor for systemic oxidative stress. Pak J Pharm Sci. 2006;19(1):62-65.
49. Hopps E, Noto D, Caimi G, Averna MR. A novel component of the metabolic syndrome: The oxidative stress. Nutrition, Metabolism and Cardiovascular Diseases. 2010;20(1):72-77. doi: 10.1016/j.numecd.2009.06.002.
50. Wenceslau CF, McCarthy CG, Szasz T, et al. Mitochondrial damage-associated molecular patterns and vascular function. Eur Heart J. 2014;35(18):1172-1177. doi: 10.1093/eurheartj/ehu047.
51. Xu XJ, Gauthier M-S, Hess DT, et al. Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J Lipid Res. 2012;53(4):792-801. doi: 10.1194/jlr.P022905.
52. Wang LY, Wang DH, Zou XY, et al. Mitochondrial functions on oocytes and preimplantation embryos. Journal of Zhejiang University SCIENCE B. 2009;10(7):483-492. doi: 10.1631/jzus.B0820379.
53. Sorensen TIA, Igosheva N, Abramov AY, et al. Maternal Diet-Induced Obesity Alters Mitochondrial Activity and Redox Status in Mouse Oocytes and Zygotes. PLoS One. 2010;5(4):e10074. doi: 10.1371/journal.pone.0010074.
54. Jones KT, Lane SIR. Chromosomal, metabolic, environmental, and hormonal origins of aneuploidy in mammalian oocytes. Exp Cell Res. 2012;318(12):1394-1399. doi: 10.1016/j.yexcr.2012.02.012.
55. Grindler NM, Moley KH. Maternal obesity, infertility and mitochondrial dysfunction: potential mechanisms emerging from mouse model systems. Mol Hum Reprod. 2013;19(8):486-494. doi: 10.1093/molehr/gat026.
56. Ремнева О.В., Яворская С.Д. Плацентарная недостаточность, профилактика, диагностика, подходы к родоразрешению, перинатальные исходы. / Под ред. Фадеевой Н.И.– Барнаул: ВН – Добрый день, 2011. [Remneva OV, Yavorskaya SD. Platsentarnaya nedostatochnost', profilaktika, diagnostika, podkhody k rodorazresheniyu, perinatal'nye iskhody. Fadeeva NI, editor. Barnaul: VN Dobryi den'; 2011 (In Russ).]
57. Roberts JM, Bell MJ. If we know so much about preeclampsia, why haven’t we cured the disease? J Reprod Immunol. 2013;99(1-2):1-9. doi: 10.1016/j.jri.2013.05.003.
58. Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part I. J Hypertens. 2005;23(1):7-17. doi: 10.1097/00004872-200501000-00004.
59. Sharma RK, Agarwal A. Role of reactive oxygen species in gynecologic diseases. Reprod Med Biol. 2004;3(4):177-199. doi: 10.1111/j.1447-0578.2004.00068.x.
60. Loy SL, Sirajudeen KNS, Hamid Jan JM. The effects of prenatal oxidative stress levels on infant adiposity development during the first year of life. J Dev Orig Health Dis. 2014;5(02):142-151. doi: 10.1017/s204017441300055x.
Supplementary files
Review
For citations:
Zhuk T.V., Yavorskaya S.D., Vostrikov V.V. Obesity, reproduction and oxidative stress. Obesity and metabolism. 2017;14(4):16-22. (In Russ.) https://doi.org/10.14341/omet2017416-22
Views:
2578
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
